Skip to main content
Back
BCAX logo

Bicara Therapeutics Inc. Common Stock

Data quality: 100%
BCAX
NASDAQ Healthcare Biotechnology
$18.39
▼ $0.02 (-0.11%)
Mkt Cap: 1.01B
Day Range
$18.11 $18.94
52-Week Range
$7.80 $20.25
Volume
324,276
50D / 200D Avg
$17.05 / $14.56
Prev Close
$18.41

Price History

Financial Trends

Peer Comparison

vs Healthcare sector median (626 peers)

Metric Stock Sector Median
P/E -14.8 0.4
P/B 2.1 2.9
ROE % -19.1 3.8
Net Margin % 3.9
Rev Growth 5Y % 10.0
D/E 0.0 0.2

Key Takeaways

Debt/Equity of 0.00 — conservative balance sheet
Negative free cash flow of -74.82M

Growth

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
-19.14%
ROIC-12.54%
Net MarginN/A
Op. MarginN/A

Safety

Debt / Equity
0.00
Current Ratio27.93
Interest Coverage0.00

Valuation

P/E Ratio
-14.82
P/B Ratio2.05
EV/EBITDAN/A
Dividend Yield0.00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 0.0 Net Income (TTM) -68.00M
ROE -19.14% ROA -11.95%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -74.82M
ROIC -12.54% FCF Growth (3Y) N/A
Safety
Debt / Equity 0.00 Current Ratio 27.93
Interest Coverage 0.00 Dividend Yield 0.00%
Valuation
P/E Ratio -14.82 P/B Ratio 2.05
P/S Ratio N/A PEG Ratio -0.56
EV/EBITDA N/A Dividend Yield 0.00%
Market Cap 1.01B Enterprise Value 518.42M

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2024 FY2023 FY2022
Revenue 0.0 0.0 0.0
Net Income -68.00M -51.99M -37.85M
EPS (Diluted) -1.25 -1.00 -0.73
Gross Profit 0.0 0.0 0.0
Operating Income -82.39M -39.89M -37.66M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2024 FY2023 FY2022
Total Assets 569.20M 233.98M 6.70M
Total Liabilities 77.32M 15.47M 23.98M
Shareholders' Equity 491.88M 218.51M -17.28M
Total Debt 738,000.0 657,000.0 0.0
Cash & Equivalents 489.71M 230.44M 4.16M
Current Assets 502.53M 231.07M 4.98M
Current Liabilities 17.99M 15.09M 23.90M